Cargando…

The impact of free antiretroviral therapy for pregnant non‐citizens and their infants in Botswana

INTRODUCTION: In December 2019, the Botswana government expanded free antiretroviral therapy (ART) to include non‐citizens. We evaluated the impact of this policy change on antenatal care (ANC), antiretroviral therapy coverage and adverse birth outcomes. METHODS: The Tsepamo Surveillance study colle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fennell, Christina, Escudero, Daniel, Zash, Rebecca, Diseko, Modiegi, Mayondi, Gloria, Mabuta, Judith, Sekoto, Tumalano, Gaolathe, Tendani, Mmalane, Mompati, Lockman, Shahin, Makhema, Joseph, Shapiro, Roger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603275/ https://www.ncbi.nlm.nih.gov/pubmed/37885157 http://dx.doi.org/10.1002/jia2.26161

Ejemplares similares

Incident HIV acquisition among pregnant women in Botswana: findings from the Tsepamo birth outcomes surveillance study
por: Mussa, Aamirah, et al.
Publicado: (2023)

Cross‐sectional trends in HIV prevalence among pregnant women in Botswana: an opportunity for PrEP?
por: Kapoor, Andrew, et al.
Publicado: (2022)

Seasonality of adverse birth outcomes in women with and without HIV in a representative birth outcomes surveillance study in Botswana
por: Caniglia, Ellen C, et al.
Publicado: (2021)

Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study
por: Zash, Rebecca, et al.
Publicado: (2018)

High risk of adverse birth outcomes among adolescents living with HIV in Botswana compared to adult women living with HIV and adolescents without HIV
por: Jackson-Gibson, Maya, et al.
Publicado: (2022)

Weight gain during pregnancy among women initiating dolutegravir in Botswana
por: Caniglia, Ellen C., et al.
Publicado: (2020)

Prevalence and outcomes of twin pregnancies in Botswana: a national birth outcomes surveillance study
por: Isaacson, Arielle, et al.
Publicado: (2021)

Lack of HIV RNA test result is a barrier to breastfeeding among women living with HIV in Botswana
por: Mayondi, Gloria Katuta, et al.
Publicado: (2021)

The Impact of Syndromic Management of Vaginal Discharge Syndrome on Adverse Birth Outcomes in Botswana
por: Fennell, Christina, et al.
Publicado: (2021)

Iron, folic acid, and multiple micronutrient supplementation strategies during pregnancy and adverse birth outcomes in Botswana
por: Caniglia, Ellen C, et al.
Publicado: (2022)

Modest reduction in adverse birth outcomes following the COVID-19 lockdown
por: Caniglia, Ellen C., et al.
Publicado: (2021)

Maternal weight and birth outcomes among women on antiretroviral treatment from conception in a birth surveillance study in Botswana
por: Zash, Rebecca, et al.
Publicado: (2021)

Mid-trimester cervical length not associated with HIV status among pregnant women in Botswana
por: Liff, Ingrid, et al.
Publicado: (2020)

Are morbidity and mortality estimates from randomized controlled trials externally valid? A comparison of outcomes among infants enrolled into an RCT or a cohort study in Botswana
por: Thivalapill, Neil, et al.
Publicado: (2021)

HIV-exposed children account for more than half of 24-month mortality in Botswana
por: Zash, Rebecca, et al.
Publicado: (2016)

Maternal biomarkers of endothelial dysfunction and pregnancy outcomes in women with and without HIV in Botswana
por: Masheto, Gaerolwe, et al.
Publicado: (2023)

Unintended pregnancy, contraceptive use, and childbearing desires among HIV-infected and HIV-uninfected women in Botswana: across-sectional study
por: Mayondi, Gloria K., et al.
Publicado: (2016)

High Prevalence of Hepatitis B Virus Infection Among People With HIV in Rural and Periurban Communities in Botswana
por: Phinius, Bonolo B, et al.
Publicado: (2023)

Epidemiological and viral characteristics of undiagnosed HIV infections in Botswana
por: Bhebhe, Lynnette, et al.
Publicado: (2022)

Safety and incidence of COVID-19 following ChAdOx1(AZD1222) COVID-19 vaccination in Botswana
por: Shava, Emily, et al.
Publicado: (2023)

Self-reported risky sexual practices among adolescents and young adults in Botswana
por: Chakalisa, Unoda, et al.
Publicado: (2019)

Health impact and cost-effectiveness of HIV testing, linkage, and early antiretroviral treatment in the Botswana Combination Prevention Project
por: Resch, Stephen C., et al.
Publicado: (2022)

HIV‐associated morbidity and mortality in a setting of high ART coverage: prospective surveillance results from a district hospital in Botswana
por: Barak, Tomer, et al.
Publicado: (2019)

Prevalence and control of hypertension in a high HIV-prevalence setting, insights from a population based study in Botswana
por: Mosepele, Mosepele, et al.
Publicado: (2023)

Feasibility of oral HIV self-testing in female sex workers in Gaborone, Botswana
por: Shava, Emily, et al.
Publicado: (2021)

Acceptability of oral HIV self-testing among female sex workers in Gaborone, Botswana
por: Shava, Emily, et al.
Publicado: (2020)

Lower academic performance among children with perinatal HIV exposure in Botswana
por: Powis, Kathleen M., et al.
Publicado: (2023)

HIV-1 Subtype C Drug Resistance Mutations in Heavily Treated Patients Failing Integrase Strand Transfer Inhibitor-Based Regimens in Botswana †
por: Seatla, Kaelo K., et al.
Publicado: (2021)

Estimated age and gender profile of individuals missed by a home-based HIV testing and counselling campaign in a Botswana community
por: Novitsky, Vlad, et al.
Publicado: (2015)

Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana
por: Bareng, Ontlametse T., et al.
Publicado: (2022)

Detecting congenital malformations - Lessons learned from the Mpepu study, Botswana
por: Ajibola, Gbolahan, et al.
Publicado: (2017)

Cancer Incidence following Expansion of HIV Treatment in Botswana
por: Dryden-Peterson, Scott, et al.
Publicado: (2015)

Phylogenetic Relatedness of Circulating HIV-1C Variants in Mochudi, Botswana
por: Novitsky, Vladimir, et al.
Publicado: (2013)

Botswana should consider expansion of free antiretroviral therapy to immigrants
por: Escudero, Daniel J, et al.
Publicado: (2019)

Correction: Cancer Incidence following Expansion of HIV Treatment in Botswana
por: Dryden-Peterson, Scott, et al.
Publicado: (2015)

Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015
por: Moyo, Sikhulile, et al.
Publicado: (2018)

Undetectable proviral deoxyribonucleic acid in an adolescent perinatally infected with human immunodeficiency virus-1C and on long-term antiretroviral therapy resulted in viral rebound following antiretroviral therapy termination: A case report with implications for clinical care
por: Koofhethile, Catherine Kegakilwe, et al.
Publicado: (2019)

Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for cabotegravir/rilpivirine use
por: Maruapula, Dorcas, et al.
Publicado: (2023)

769. Mortality Among Inpatients After the Initiation of ‘Treat All’ With Dolutegravir in Botswana
por: Klinger, Amanda E, et al.
Publicado: (2020)

2572. Decreased T-Cell Response, but Appropriate Antibody Production to Tetanus Vaccine Among HIV-Exposed Uninfected Infants in Botswana
por: Smith, Christiana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3h7lurr4uil8o1e3icu4r5stpk